Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella

Journal of Medical Microbiology

Volumn 46, Issue 2, 1997, Pages 129-138

  Whittle, Belinda L ^a   Lee, Eva ^a   Weir, Ron C ^a   Verma, Naresh K ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENCEPHALITIS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAGELLUM; GENETIC ENGINEERING; MICROBIAL ATTENUATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; VACCINATION; VIRUS NEUTRALIZATION;

EID: 0031039749     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-2-129     Document Type: Article

References (50)

1. Curtiss RJ, Hassan O, Herr J et al. Nonrecombinant and recombinant avirulent salmonella vaccines. Proceedings of the Symposium Recombinant and Synthetic Vaccines. New Delhi, India. 1992.
2. Cárdenas L, Clements JD. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine 1993; 11: 126-135.
3. Stocker BAD, Newton SM. Immune responses to epitopes inserted in salmonella flagellin. Int Rev Immunol 1994; 11: 167-178.
4. Hoiseth SK, Stocker BAD. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291: 238-239.
5. Dougan G, Maskell D, Pickard D, Hormaeche C. Isolation of stable aroA mutants of Salmonella typhi Ty2: properties and preliminary characterization in mice. Mol Gen Genet 1987; 207: 402-405.
6. Robertsson JÅ, Lindberg AA, Hoiseth SK, Stocker BAD. Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun 1983; 41: 742-750.
7. Mukkur TKS, McDowell GH, Stocker BAD, Lascelles AK. Protection against experimental Salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium. J Med Microbiol 1987; 24: 11-19.
8. Smith BP, Reina-Guerra M, Hoiseth SK et al. Aromatic-dependent Salmonella typhimurium as modified live vaccine for calves. Am J Vet Res 1984; 45: 59-66.
9. Majurian WR, Kasper SJ, Brey RN. Expression of heterologous epitopes as recombinant flagella on the surface of attenuated Salmonella. In: Vaccine 89. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press. 1989: 277-281.
10. Newton SMC, Jacob CO, Stocker BAD. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 1989; 244: 70-72.
11. Verma NK, Ziegler HK, Stocker BAD, Schoolnik GK. Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella. Vaccine 1995; 13: 235-244.
12. Verma NK, Ziegler HK, Wilson M et al. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 1995; 13: 142-150.
13. Newton SM, Manning WC, Hovl M, Stocker BAD. Aromatic-dependent Salmonella with foreign epitope insert in flagellin as live vaccine. In: Vaccines 90. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press. 1990: 439-445.
14. Westaway EG, Brinton MA, Gaidamovich SY et al. Flaviviridae, Intervirology 1985; 24: 183-192.
15. Marshall ID. Murray Valley and Kunjin encephalitis. In: Monath TP (ed) The arboviruses: epidemiology and ecology. Boca Raton, FL, CRC Press. 1988: 151-189.
16. Chambers TJ, Hahn, CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 1990; 44: 696-688.
17. Doherty RL. Arthropod-borne viruses in Australia, 1973-1976. Aust J Exp Biol Med Sci 1977; 55: 103-130.
18. French EL. A review of arthropod-borne virus infections affecting man and animals in Australia. Aust J Exp Biol Med Sci 1973; 51: 131-158.
19. Theiler M, Smith HH. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J Exp Med 1937; 65: 767-786.
20. Kunz C, Heinz FX, Hofmann H. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol 1980; 6: 103-109.
21. Yu YX, Zhang GM, Guo YP, Ao J, Li HM. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA-14-14-2) for children. Am J Trop Med Hyg 1988; 39: 214-217.
22. Okuda K, Itoh K, Miyake K, Morita M, Ogonuki M, Matsui S. Purification of Japanese encephalitis virus vaccine by zonal centrifugation. J Clin Microbiol 1975; 1: 96-101.
23. Hill AB, Lobigs M, Blanden RV, Kulkami A, Mullbacher A. The cellular immune response to Flavivirus. In: Thomas DB (ed) Viruses and the cellular immune response. Marcel Dekker, Inc. 1993: 363-387.
24. Heinz FX, Mandl C, Holzmann H, Guirakhoo F, Tuma W, Kunz C. The antigenic structure and function of the flavivirus envelope protein E. 2nd International Symposium on Positive Strand Viruses, Vienna, Austria, 1989.
25. Mandl CW, Guirakhoo F, Holzmann H, Heinz FX, Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol 1989; 63: 564-571.
26. Mathews JH, Roehrig JT, Brubaker JR, Hunt AR, Allan JE. A synthetic peptide to the E glycoprotein of Murray Valley Encephalitis Virus defines multiple virus-reactive T- and B-cell epitopes. J Virol 1992; 66: 6555-6562.
27. McMinn PC, Lee E, Hartley S, Roehrig JT, Dalgarno L, Weir RC. Murray Valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology 1995; 211: 10-20.
28. Stanley KK, Luzio JP. Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO J 1984; 3: 1429-1434.
29. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning; a laboratory manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory. 1982: 16-17.
30. Dalgarno L, Trent DW, Strauss JH, Rice CM. Partial nucleotide sequence of the Murray Valley encephalitis virus genome. comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J Mol Biol 1986; 187: 309-323.
31. Rice CM, Dalgarno L, Galler R, Hahn YS, Strauss EG, Strauss JH. Molecular cloning of flavivirus genomes for comparative analysis and expression. In: Bauer H, Klenk H-D, Scholtissek C (eds) Modern trends in virology. Berlin: Springer-Verlag. 1988: 83-97.
32. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979; 7: 1513-1523.
33. Dower WJ, Miller JF, Ragsdale CW. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res 1988; 16: 6127-6145.
34. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
35. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4354.
36. Ho ASY, Mietzner TA, Smith AJ, Schoolnik GK. The pili of Aeromonas hydrophila: identification of an environmentally regulated "minipilin". J Exp Med 1990; 172: 795-806.
37. Hawkes RA, Roehrig JT, Hunt AR, Moore GA. Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol 1988; 69: 1105-1109.
38. Guirakhoo F, Bolin RA, Roehrig JT. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 1992; 191: 921-931.
39. Nowak T, Wengler G. Analysis of disulfides present in the membrane proteins of the West Nile flavivirus. Virologv 1987; 156: 127-137.
40. Guirakhoo F, Heinz FX, Kunz C. Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH. Virology 1989; 169: 90-99.
41. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 1995; 375: 291-298.
42. Mandl CW, Heinz FX, Kunz C. Sequence of the structural proteins of tick-borne encephalitis virus (Western subtype) and comparative analysis with other flaviviruses. Virology 1988; 166: 197-205.
43. Wei L-N, Joys TM. Covalent structure of three phase-1 flagellar filament proteins of Salmonella. J Mol Biol 1985; 186: 791-803.
44. McAda PC, Mason PW, Schmaljohn CS, Dalrymple JM, Mason TL, Fournier MJ. Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology 1987; 158: 348-360.
45. Castle E, Nowak T, Leidner U, Wengler G, Wengler G. Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus West Nile virus and of the genome sequence of these proteins. Virology 1985; 145: 227-236.
46. Trent DW, Kinney RM, Johnson BJB et al. Partial nucleotide sequence of St Louis encephalitis virus RNA: structural proteins, NS1, 2a and 2b. Virology 1987; 156: 293-304.
47. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 1985; 229: 726-733.
48. Mason PW, McAda PC, Mason TL, Fournier MJ. Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major nonstructural protein NS1. Virology 1987; 161: 262-267.
49. Deubel V, Kinney RM, Trent DW. Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology 1986; 155: 365-377.
50. Zhao B, Mackow E, Buckler-White A et al. Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology 1986; 155: 77-88.